ALCAM and VCAM-1 as potential urinary biomarkers in Caucasian lupus patients

被引：0
|
作者：
Habazi, Deena [1 ]
Vanarsa, Kamala [1 ]
Stanley, Samantha [1 ]
Gokaraju, Sirisha [1 ]
Ding, Huihua [1 ]
Parodis, Ioannis [2 ]
Gunnarsson, Iva [2 ]
Mohan, Chandra [1 ]
机构：
[1] Univ Houston, Houston, TX 77004 USA
[2] Karolinska Inst, Stockholm, Sweden
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
175.17
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
    Andrese Aline Gasparin
    Nicole Pamplona Bueno de Andrade
    Vanessa Hax
    Penélope Esther Palominos
    Marina Siebert
    Romulo Marx
    Pedro Guilherme Schaefer
    Francisco Veríssimo Veronese
    Odirlei André Monticielo
    BMC Rheumatology, 4
  • [12] URINARY SOLUBLE VCAM-1 IS A USEFUL BIOMARKER OF DISEASE ACTIVITY AND TREATMENT RESPONSE IN LUPUS NEPHRITIS
    Gasparin, A. A.
    Pamplona Bueno de Andrade, N.
    Hax, V.
    Palominos, P.
    Siebert, M.
    Marx, R.
    Shaefer, P.
    Verissimo Veronese, F.
    Monticielo, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1502 - 1503
  • [13] Novel insights on the role of VCAM-1 and ICAM-1: Potential biomarkers for cardiovascular diseases
    Kaur, Rupinder
    Singh, Varinder
    Kumari, Pratima
    Singh, Ravinder
    Chopra, Hitesh
    Bin Emran, Talha
    ANNALS OF MEDICINE AND SURGERY, 2022, 84
  • [14] Correlation between circadian blood pressure rhythm, VCAM-1 serum level, and urinary VCAM-1 excretion in preeclampsia
    Heyl, W
    Heintz, B
    Reister, F
    Faridi, A
    Witte, K
    Lemmer, B
    Rath, W
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2000, 60 (10) : 519 - 522
  • [15] Urinary soluble VCAM-1 in systemic lupus erythematosus: A clinical marker for monitoring disease activity and damage
    Molad, Y
    Miroshnik, E
    Sulkes, J
    Pitlik, S
    Weinberger, A
    Monselise, Y
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (03) : 403 - 406
  • [16] The correlation between VCAM-1 and renal injury of systemic lupus erythematosus
    Diliniger, E.
    Lijun, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 854 - 855
  • [17] Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis
    Yu, Kelvin Y. C.
    Yung, Susan
    Chau, Mel K. M.
    Tang, Colin S. O.
    Yap, Desmond Y. H.
    Tang, Alexander H. N.
    Ying, Shirley K. Y.
    Lee, Cheuk Kwong
    Chan, Tak Mao
    LUPUS, 2021, 30 (07) : 1039 - 1050
  • [18] Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
    Soliman, Samar A.
    Haque, Anam
    Vanarsa, Kamala
    Zhang, Ting
    Ismail, Faten
    Lee, Kyung Hyun
    Pedroza, Claudia
    Greenbaum, Larry A.
    Mason, Sherene
    Hicks, M. John
    Wenderfer, Scott E.
    Mohan, Chandra
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [19] Molecular Pathways: VCAM-1 as a Potential Therapeutic Target in Metastasis
    Chen, Qing
    Massague, Joan
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5520 - 5525
  • [20] Relationship between lupus nephritis activity and the serum level of soluble VCAM-1
    Ikeda, Y
    Fujimoto, T
    Ameno, M
    Shiiki, H
    Dohi, K
    LUPUS, 1998, 7 (05) : 347 - 354
12345